The Expression of Proto-Oncogene


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Apr 2022
Historique:
received: 23 03 2022
revised: 17 04 2022
accepted: 22 04 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

The

Identifiants

pubmed: 35563163
pii: ijms23094772
doi: 10.3390/ijms23094772
pmc: PMC9105369
pii:
doi:

Substances chimiques

ERG protein, human 0
Oncogene Proteins, Fusion 0
Proto-Oncogene Proteins c-ets 0
Transcriptional Regulator ERG 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Prostate Cancer Foundation
ID : YI, 2012
Organisme : Canadian Cancer Society
ID : #40039

Références

Cancer Res. 2006 Apr 1;66(7):3396-400
pubmed: 16585160
Dev Biol. 2021 May;473:1-14
pubmed: 33453264
Science. 2005 Oct 28;310(5748):644-8
pubmed: 16254181
Mol Cancer Res. 2013 Nov;11(11):1349-61
pubmed: 23918819
Oncol Rep. 2017 Jan;37(1):201-208
pubmed: 28004109
Mol Cancer. 2021 Aug 27;20(1):109
pubmed: 34452613
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6868-6877
pubmed: 30886105
Cell Rep. 2019 Oct 29;29(5):1203-1220.e7
pubmed: 31665634
Anticancer Res. 2011 Feb;31(2):403-10
pubmed: 21378318
Mol Cancer Ther. 2019 Sep;18(9):1577-1586
pubmed: 31296553
CNS Neurosci Ther. 2017 Dec;23(12):947-960
pubmed: 28961379
Front Cell Dev Biol. 2021 Feb 09;9:623809
pubmed: 33634124
Cancer Cell Int. 2020 Jul 16;20:312
pubmed: 32694934
Int J Mol Sci. 2015 Apr 16;16(4):8591-606
pubmed: 25894226
Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):489-500
pubmed: 23288152
Nat Rev Urol. 2011 Jun 21;8(8):428-39
pubmed: 21691304
Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1497-509
pubmed: 22736790
Prostate. 2018 Dec;78(16):1311-1320
pubmed: 30051493
Genesis. 2018 Dec;56(11-12):e23257
pubmed: 30318758
Development. 2012 Nov;139(21):3973-85
pubmed: 22932696
Life (Basel). 2021 Oct 16;11(10):
pubmed: 34685470
ACS Med Chem Lett. 2015 Aug 31;6(10):1071-4
pubmed: 26487914
Oncogene. 2005 May 26;24(23):3847-52
pubmed: 15750627
Am J Respir Cell Mol Biol. 2017 Jul;57(1):121-131
pubmed: 28248553
Cancer Res. 2005 May 15;65(10):4218-27
pubmed: 15899813
Nat Rev Urol. 2017 Nov;14(11):683-696
pubmed: 28895566
BMJ Open. 2019 Mar 8;9(3):e025161
pubmed: 30852544
IUBMB Life. 2021 Apr;73(4):618-642
pubmed: 33476088
Prostate. 2021 Feb;81(2):109-117
pubmed: 33141952
Mol Biol Cell. 2021 Mar 1;32(5):402-412
pubmed: 33405954
PLoS Biol. 2021 Sep 22;19(9):e3001394
pubmed: 34550965
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):e17-e24
pubmed: 29467221
Cancer Gene Ther. 2022 Apr 7;:
pubmed: 35393570
Genes Dev. 2015 Sep 15;29(18):1915-29
pubmed: 26385962
Transl Oncol. 2010 Jun 01;3(3):195-203
pubmed: 20563261
Life (Basel). 2021 Jun 21;11(6):
pubmed: 34205581
Cell Res. 2009 Jun;19(6):683-97
pubmed: 19365403
NAR Cancer. 2021 Jan 27;3(1):zcaa046
pubmed: 33554122
Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):223-32
pubmed: 18162609
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6983-6990
pubmed: 31486498
J Neurooncol. 2019 Sep;144(3):545-551
pubmed: 31422498
Nature. 2011 Jan 20;469(7330):343-9
pubmed: 21248841
Int J Oncol. 2017 Apr;50(4):1087-1096
pubmed: 28350128
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2105-10
pubmed: 18245377
Nat Commun. 2021 Jul 6;12(1):4147
pubmed: 34230470
J Biol Chem. 2012 Feb 24;287(9):6582-91
pubmed: 22235125
Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8584-8592
pubmed: 32220959
Front Cell Dev Biol. 2021 Jun 16;9:623782
pubmed: 34222223
Clin Cancer Res. 2018 Sep 15;24(18):4551-4565
pubmed: 29844131
BMC Urol. 2022 Mar 19;22(1):37
pubmed: 35305591
Int J Clin Exp Pathol. 2015 Feb 01;8(2):1878-88
pubmed: 25973080
Dev Cell. 2015 Jan 12;32(1):82-96
pubmed: 25584796
J Clin Invest. 2020 Nov 2;130(11):5924-5941
pubmed: 32701507
Cancers (Basel). 2022 Feb 22;14(5):
pubmed: 35267426
PLoS Genet. 2021 Jul 27;17(7):e1009708
pubmed: 34314419
Prostate. 2007 Jan 1;67(1):61-73
pubmed: 17034033
Oncogene. 2014 Oct 30;33(44):5183-92
pubmed: 24186205
Cancers (Basel). 2014 Feb 26;6(1):436-58
pubmed: 24577242
Eur Urol Oncol. 2021 Mar 31;:
pubmed: 33812851
Cancers (Basel). 2021 Jun 30;13(13):
pubmed: 34208794
Oncogene. 2008 Sep 11;27(40):5348-53
pubmed: 18542058
Pathol Oncol Res. 2019 Oct;25(4):1423-1429
pubmed: 30357756
Gene. 2016 Nov 30;593(2):292-301
pubmed: 27570179
Carcinogenesis. 2012 Dec;33(12):2558-67
pubmed: 23027626
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Oncogene. 2016 Jan 28;35(4):403-14
pubmed: 25915839
World J Urol. 2020 Sep;38(9):2185-2196
pubmed: 31745645
Trends Cancer. 2016 Mar;2(3):116-120
pubmed: 28741531
Cancer Res. 2013 Oct 1;73(19):6068-79
pubmed: 23913826
Oncogene. 2019 Jun;38(25):4977-4989
pubmed: 30820039
Chin J Cancer. 2013 Nov;32(11):594-603
pubmed: 24206917
Oncogene. 2019 May;38(22):4397-4411
pubmed: 30718921
Sci Rep. 2018 Aug 27;8(1):12868
pubmed: 30150711
BMC Cancer. 2021 Jul 26;21(1):856
pubmed: 34311724
Cancer Res. 2020 Nov 1;80(21):4612-4619
pubmed: 32934023
J Pers Med. 2021 Feb 17;11(2):
pubmed: 33671331
Nat Genet. 2009 May;41(5):509-10
pubmed: 19399032
Shock. 2022 Feb 1;57(2):309-315
pubmed: 34907119
Cold Spring Harb Perspect Biol. 2012 Sep 01;4(9):a011189
pubmed: 22952397
Cancer Med. 2022 May;11(10):2117-2124
pubmed: 35312170
FEBS Lett. 2019 Sep;593(18):2585-2595
pubmed: 31271645
Eur Urol Open Sci. 2020 Dec 02;23:1-8
pubmed: 34337483
Cancers (Basel). 2022 Mar 17;14(6):
pubmed: 35326693
Transl Oncol. 2020 Apr;13(4):100747
pubmed: 32217460
Cancer Treat Res Commun. 2021;29:100451
pubmed: 34507017
Oncotarget. 2020 Apr 14;11(15):1321-1333
pubmed: 32341752
Diagnostics (Basel). 2020 Dec 20;10(12):
pubmed: 33419298
Circ Res. 2008 Nov 7;103(10):1147-54
pubmed: 18832752
Onco Targets Ther. 2020 Apr 05;13:2925-2934
pubmed: 32308425
Eur Urol. 2016 Nov;70(5):740-748
pubmed: 27108162
Medicines (Basel). 2019 Jul 30;6(3):
pubmed: 31366128
Neoplasia. 2008 Feb;10(2):177-88
pubmed: 18283340
J Carcinog. 2011;10:37
pubmed: 22279422
Oncogenesis. 2021 Mar 12;10(3):26
pubmed: 33712555
Physiol Rev. 2021 Jul 1;101(3):797-855
pubmed: 33356915
Curr Cancer Drug Targets. 2021;21(9):749-767
pubmed: 34077345
PLoS One. 2014 Feb 05;9(2):e86824
pubmed: 24505269
Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):1000-1008
pubmed: 33627383
Front Oncol. 2020 Dec 16;10:584505
pubmed: 33425737
Cancers (Basel). 2021 Feb 25;13(5):
pubmed: 33669024
Oncogene. 2020 Jul;39(30):5241-5251
pubmed: 32555329
Curr Mol Med. 2014;14(9):1226-37
pubmed: 25323998
Dis Markers. 2019 Dec 12;2019:5085373
pubmed: 31915468
Nature. 2019 Jul;571(7765):413-418
pubmed: 31243372
Cancer Cell. 2010 May 18;17(5):443-54
pubmed: 20478527
Mol Cell. 2020 Sep 17;79(6):1008-1023.e4
pubmed: 32871104
Medicine (Baltimore). 2021 Jun 11;100(23):e26135
pubmed: 34114996
J Obstet Gynaecol Res. 2021 Jun;47(6):1946-1957
pubmed: 33827148
Cancer Res. 2008 Jan 1;68(1):73-80
pubmed: 18172298
Nat Commun. 2021 Sep 7;12(1):5325
pubmed: 34493733
Am J Cardiol. 2017 Oct 15;120(8S):S71-S79
pubmed: 29025573

Auteurs

Ealia Khosh Kish (E)

Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada.

Muhammad Choudhry (M)

Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada.

Yaser Gamallat (Y)

Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada.
Alberta Precision Laboratories, Calgary, AB T2V 1P9, Canada.

Sabrina Marsha Buharideen (SM)

Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada.
Alberta Precision Laboratories, Calgary, AB T2V 1P9, Canada.

Dhananjaya D (D)

Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada.
Alberta Precision Laboratories, Calgary, AB T2V 1P9, Canada.

Tarek A Bismar (TA)

Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada.
Alberta Precision Laboratories, Calgary, AB T2V 1P9, Canada.
Departments of Oncology, Biochemistry and Molecular Biology, Calgary, AB T2V 1P9, Canada.
Tom Baker Cancer Center, Arnie Charbonneau Cancer Institute, Calgary, AB T2V 1P9, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH